BALTIMORE, Oct. 5 (UPI) -- Baltimore researchers have successfully used an experimental DNA-based vaccine to protect against ragweed allergies, commonly known as hay fever.
Patients receiving the vaccine showed an average 60 percent reduction in allergy symptoms compared to those receiving a placebo, say researchers at The Johns Hopkins University School of Medicine.
Continue reading Experimental hay fever vaccine effective.
